Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia

World Neurosurg. 2015 Jun;83(6):1120-1126.e1. doi: 10.1016/j.wneu.2015.01.036. Epub 2015 Feb 12.

Abstract

Background: Delayed cerebral ischemia (DCI) is a major cause of morbidity and mortality in aneurysmal subarachnoid hemorrhage. Endovascular management of this condition offers a new hope in preventing adverse outcome; however, a uniform standard of practice is lacking owing to a paucity of clinical trials. We conducted an international survey on the use of investigative and endovascular techniques in the treatment of DCI to assess the variability of current practice.

Methods: Neurovascular neurosurgeons and neuroradiologists were contacted through professional societies from America, United Kingdom, Europe, and Australasia. Members were invited to complete a 13-item questionnaire regarding screening techniques, first-line and second-line therapies in endovascular intervention, and the role of angioplasty. Answers were compared using χ(2) testing for nonparametric data.

Results: Data from 344 respondents from 32 countries were analyzed: 167 non-United States and 177 U.S.

Respondents: More than half of all clinicians had 10+ years of experience in units with a mixture of higher and lower case volumes. Daily transcranial Doppler ultrasonography was the most commonly used screening technique by both U.S. (70%) and non-U.S. (53%) practitioners. Verapamil was the most common first-line therapy in the United States, whereas nimodipine was most popular in non-U.S. countries. Angioplasty was performed by 83% of non-U.S. and 91% of U.S. clinicians in the treatment of vasospasm; however, more U.S. clinicians reported using angioplasty for distal vasospasm.

Conclusions: Treatment practices for DCI vary considerably, with the greatest variability in the choice of agent for intra-arterial therapy. Our data demonstrate the wide variation of approaches in use at present. However, without further clinical trials and development of a uniform standard of best practice, variability in treatment and outcome for DCI is likely to continue.

Keywords: Angioplasty; Cerebral vasospasm; Delayed cerebral ischemia; Intra-arterial treatment; Subarachnoid hemorrhage; Survey; Transcranial Doppler.

MeSH terms

  • Adult
  • Australasia
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / etiology
  • Brain Ischemia / surgery*
  • Disease Management
  • Endovascular Procedures* / methods
  • Europe
  • Female
  • Health Care Surveys
  • Humans
  • International Cooperation
  • Male
  • Middle Aged
  • Neuroradiography / statistics & numerical data
  • Neurosurgery / statistics & numerical data
  • Nimodipine / therapeutic use
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Subarachnoid Hemorrhage / complications*
  • Subarachnoid Hemorrhage / surgery
  • Surveys and Questionnaires
  • Time Factors
  • Ultrasonography, Doppler, Transcranial
  • United Kingdom
  • United States
  • Vasodilator Agents / therapeutic use
  • Vasospasm, Intracranial / diagnostic imaging
  • Vasospasm, Intracranial / etiology
  • Vasospasm, Intracranial / surgery*
  • Verapamil / therapeutic use

Substances

  • Vasodilator Agents
  • Nimodipine
  • Verapamil